These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 20429628)
21. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma. Wang ZF; Liu QJ; Liao SQ; Yang R; Ge T; He X; Tian CP; Liu W Tumori; 2011; 97(4):540-6. PubMed ID: 21989446 [TBL] [Abstract][Full Text] [Related]
22. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. Takano T; Miyauchi A; Yokozawa T; Matsuzuka F; Maeda I; Kuma K; Amino N Cancer Res; 1999 Sep; 59(18):4542-5. PubMed ID: 10493503 [TBL] [Abstract][Full Text] [Related]
23. Expression of MAGE A1-6 and the clinical characteristics of papillary thyroid carcinoma. Lee HS; Kim SW; Hong JC; Jung SB; Jeon CH; Park JW; Park SY; Lee KD Anticancer Res; 2013 Apr; 33(4):1731-5. PubMed ID: 23564824 [TBL] [Abstract][Full Text] [Related]
24. Detecting thyrotropin receptor mRNA from peripheral blood of patients with differentiated thyroid cancer rules out non-aggressive cases. Janković Miljuš JR; Prosenc Zmrzljak U; Košir R; Jovanović M; Đorić IĐ; Rončević JV; Išić Denčić TM; Šelemetjev SA Ann Clin Biochem; 2024 Sep; 61(5):338-346. PubMed ID: 38195090 [TBL] [Abstract][Full Text] [Related]
25. Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas. Gyftaki R; Liacos C; Politi E; Liontos M; Saltiki K; Papageorgiou T; Thomakos N; Haidopoulos D; Rodolakis A; Alevizaki M; Bamias A; Dimopoulos A Int J Gynecol Cancer; 2014 Jun; 24(5):851-6. PubMed ID: 24844218 [TBL] [Abstract][Full Text] [Related]
26. Management of microcarcinomas (papillary and medullary) of the thyroid. Wu LS; Milan SA Curr Opin Oncol; 2013 Jan; 25(1):27-32. PubMed ID: 23042124 [TBL] [Abstract][Full Text] [Related]
27. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. Xing M; Usadel H; Cohen Y; Tokumaru Y; Guo Z; Westra WB; Tong BC; Tallini G; Udelsman R; Califano JA; Ladenson PW; Sidransky D Cancer Res; 2003 May; 63(9):2316-21. PubMed ID: 12727856 [TBL] [Abstract][Full Text] [Related]
28. Papillary thyroid microcarcinoma: a surgical perspective. Sakorafas GH; Giotakis J; Stafyla V Cancer Treat Rev; 2005 Oct; 31(6):423-38. PubMed ID: 16005155 [TBL] [Abstract][Full Text] [Related]
29. Prognostic parameters for recurrence of papillary thyroid microcarcinoma. Kim TY; Hong SJ; Kim JM; Kim WG; Gong G; Ryu JS; Kim WB; Yun SC; Shong YK BMC Cancer; 2008 Oct; 8():296. PubMed ID: 18851763 [TBL] [Abstract][Full Text] [Related]
30. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer. Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345 [TBL] [Abstract][Full Text] [Related]
31. [Detection of malignancy markers in thyroid nodules by reverse transcriptase polymerase chain reaction (RT-PCR)]. Pineda P; Rojas P; Liberman C; Moyano L; Goecke I Rev Med Chil; 2003 Sep; 131(9):965-72. PubMed ID: 14635582 [TBL] [Abstract][Full Text] [Related]
32. TSH receptor status of thyroid neoplasms--TaqMan RT-PCR analysis of archival material. Sheils OM; Sweeney EC J Pathol; 1999 May; 188(1):87-92. PubMed ID: 10398146 [TBL] [Abstract][Full Text] [Related]
33. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data]. Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943 [TBL] [Abstract][Full Text] [Related]
35. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients. Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540 [TBL] [Abstract][Full Text] [Related]
36. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization. Tanaka K; Inoue H; Miki H; Komaki K; Monden Y Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520 [TBL] [Abstract][Full Text] [Related]
37. Identification of key genes associated with papillary thyroid microcarcinoma characteristics by integrating transcriptome sequencing and weighted gene co-expression network analysis. Yang F; Lian M; Ma H; Feng L; Shen X; Chen J; Fang J Gene; 2022 Feb; 811():146086. PubMed ID: 34856364 [TBL] [Abstract][Full Text] [Related]
38. Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. Takano T; Miyauchi A; Yokozawa T; Matsuzuka F; Liu G; Higashiyama T; Morita S; Kuma K; Amino N Cancer Res; 1998 Nov; 58(21):4913-7. PubMed ID: 9809999 [TBL] [Abstract][Full Text] [Related]
39. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression. Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390 [TBL] [Abstract][Full Text] [Related]
40. Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma. Zhou C; Li J; Wang Y; Xue S; Zhang Y Oncol Lett; 2019 Jan; 17(1):183-194. PubMed ID: 30655754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]